McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.
Acta Biomater. 2017 Nov;63:50-63. doi: 10.1016/j.actbio.2017.09.011. Epub 2017 Sep 13.
Salvaging or functional replacement of damaged tissue caused by stroke in the brain remains a major therapeutic challenge. In situ gelation and retention of a hydrogel bioscaffold composed of 8mg/mL extracellular matrix (ECM) can induce a robust invasion of cells within 24h and potentially promote a structural remodeling to replace lost tissue. Herein, we demonstrate a long-term retention of ECM hydrogel within the lesion cavity. A decrease of approximately 32% of ECM volume is observed over 12weeks. Lesion volume, as measured by magnetic resonance imaging and histology, was reduced by 28%, but a battery of behavioral tests (bilateral asymmetry test; footfault; rotameter) did not reveal a therapeutic or detrimental effect of the hydrogel. Glial scarring and peri-infarct astrocytosis were equivalent between untreated and treated animals, potentially indicating that permeation into host tissue is required to exert therapeutic effects. These results reveal a marked difference of biodegradation of ECM hydrogel in the stroke-damaged brain compared to peripheral soft tissue repair. Further exploration of these structure-function relationships is required to achieve a structural remodeling of the implanted hydrogel, as seen in peripheral tissues, to replace lost tissue and promote behavioral recovery.
In situ gelation of ECM is essential for its retention within a tissue cavity. The brain is a unique environment with restricted access that necessitates image-guided delivery through a thin needle to access tissue cavities caused by stroke, as well as other conditions, such as traumatic brain injury or glioma resection. Knowledge about a brain tissue response to implanted hydrogels remains limited, especially in terms of long-term effects and potential impact on behavioral function. We here address the long-term retention of hydrogel within the brain environment, its impact on behavioral function, as well as its ability to reduce further tissue deformation caused by stroke. This study highlights considerable differences in the brain's long-term response to an ECM hydrogel compared to peripheral soft tissue. It underlines the importance of understanding the effect of the structural presence of a hydrogel within a cavity upon host brain tissue and behavioral function. As demonstrated herein, ECM hydrogel can fill a cavity long-term to reduce further progression of the cavity, while potentially serving as a reservoir for local drug or cell delivery.
在大脑中,对因中风而受损的组织进行修复或功能替代仍然是一个重大的治疗挑战。由 8mg/ml 细胞外基质(ECM)组成的水凝胶生物支架的原位凝胶化和保留可以在 24 小时内引起细胞的强烈浸润,并有可能促进结构重塑以替代丢失的组织。在此,我们证明 ECM 水凝胶在病变腔内的长期保留。在 12 周内,观察到 ECM 体积减少约 32%。通过磁共振成像和组织学测量的病变体积减少了 28%,但一系列行为测试(双侧不对称测试;足误;转筒仪)并未显示水凝胶的治疗或有害作用。未处理和处理动物之间的神经胶质瘢痕和梗死周围星形细胞增生没有差异,这可能表明渗透到宿主组织中是发挥治疗作用所必需的。这些结果揭示了 ECM 水凝胶在中风损伤大脑中的生物降解与周围软组织修复之间的显著差异。需要进一步探索这些结构-功能关系,以实现植入水凝胶的结构重塑,就像在周围组织中看到的那样,以替代丢失的组织并促进行为恢复。
ECM 的原位凝胶化对于其在组织腔中的保留是必不可少的。大脑是一个独特的环境,其进入受限,这需要通过细针进行图像引导输送,以进入中风引起的组织腔,以及其他情况,如创伤性脑损伤或神经胶质瘤切除。关于植入水凝胶对大脑组织的反应的知识仍然有限,特别是在长期影响和对行为功能的潜在影响方面。我们在这里解决了水凝胶在脑环境中的长期保留问题、其对行为功能的影响以及其减少中风引起的进一步组织变形的能力。这项研究突出了 ECM 水凝胶在大脑中的长期反应与周围软组织之间的显著差异。它强调了理解水凝胶在腔内的结构存在对宿主脑组织和行为功能的影响的重要性。如本文所述,ECM 水凝胶可以长期填充腔以减少腔的进一步进展,同时可能作为局部药物或细胞递送的储库。